NCT03927820Completed
A Pharmacist-Led Intervention to Increase Inhaler Access and Reduce Hospital Readmissions (PILLAR)
Source: ClinicalTrials.gov · Last updated 27 Jul 2026
Brief summary (registry, in English)
The goal of this study is to assess the impact of pharmacist-led benefits investigations and application of clinical practice guidelines on patient access to inhalers and time to hospital readmission or Emergency Department (ED) visit.
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 914 (actual)
- First submitted
- 23 Apr 2019
- Start date
- 9 Sept 2019
- Primary completion date
- 1 Jun 2026
- Lead sponsor
- Vanderbilt University Medical Center
- NCT number
- NCT03927820
What you commit to
- Study type: Interventional
- Participants enrolled: 914
- From 9 Sept 2019 to the primary completion date, 1 Jun 2026
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study design.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- no medication insurance
Other illness
- Diagnosis of graft versus host disease (GVHD)
Other
- Diagnosis of cystic fibrosis
- discharge to any post-acute care facility or inpatient hospice
- death during hospitalization
Who the study is looking for
- Adult patient admitted to Vanderbilt University Medical Center (VUMC) (excluding surgery services)
- on a long acting inhaler or prescribed a long acting inhaler during admission.
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Save your city in your profile to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Vanderbilt Univeristy Medical Center Coordinator of this site? Confirm its status | Nashville | United States | Unknown status |
Related publications
- A Pharmacist-Led Intervention to Increase Inhaler Access and Reduce Hospital Readmission (PILLAR): A Randomized Controlled Trial.CHEST Pulm · 2026 · PMID 42548423
This page is information, not medical advice. Discuss any trial with your doctor.